TrialAmerican journal of hematology2014

Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia.

Ohad Benjamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.